Merit Medical Systems Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 12/206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 103.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Merit Medical Systems Inc's Score
Industry at a Glance
Industry Ranking
12 / 206
Overall Ranking
69 / 4562
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
11
analysts
Buy
Current Rating
103.000
Target Price
+23.93%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Merit Medical Systems Inc Highlights
StrengthsRisks
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 17.86% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.36B.
Undervalued
The company’s latest PE is 43.52, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 64.29M shares, decreasing 5.30% quarter-over-quarter.
Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of medical devices used in interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and original equipment manufacturer. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its product portfolio of medical devices and accessories is used in lead management procedures for patients who need a pacemaker, or an implantable cardioverter-defibrillator lead removed or replaced. Its products are used in clinical areas, such as radiology, electrophysiology and more. It also manufactures hemostatic devices under the brand names StatSeal and WoundSeal.
Ticker SymbolMMSI
CompanyMerit Medical Systems Inc
CEOAronson (Martha Goldberg)
Websitehttps://www.merit.com/
FAQs
What is the current price of Merit Medical Systems Inc (MMSI)?
The current price of Merit Medical Systems Inc (MMSI) is 87.390.
What is the symbol of Merit Medical Systems Inc?
The ticker symbol of Merit Medical Systems Inc is MMSI.
What is the 52-week high of Merit Medical Systems Inc?
The 52-week high of Merit Medical Systems Inc is 111.450.
What is the 52-week low of Merit Medical Systems Inc?
The 52-week low of Merit Medical Systems Inc is 78.116.
What is the market capitalization of Merit Medical Systems Inc?
The market capitalization of Merit Medical Systems Inc is 5.18B.
What is the net income of Merit Medical Systems Inc?
The net income of Merit Medical Systems Inc is 120.36M.
Is Merit Medical Systems Inc (MMSI) currently rated as Buy, Hold, or Sell?
According to analysts, Merit Medical Systems Inc (MMSI) has an overall rating of Buy, with a price target of 103.000.
What is the Earnings Per Share (EPS TTM) of Merit Medical Systems Inc (MMSI)?
The Earnings Per Share (EPS TTM) of Merit Medical Systems Inc (MMSI) is 2.008.